Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jan Sahai"'
Autor:
Jan Sahai, Shurjeel H. Choudhri, Richard Long, Mark Hawken, Samuel Gathua, George O. Minyiri, Fred Y. Aoki, Daniel S. Sitar, William M. Watkins
Publikováno v:
Clinical Infectious Diseases. 25:104-111
To test the hypothesis that antituberculous drug disposition is altered in patients with AIDS, we studied the steady-state pharmacokinetics of isoniazid (300 mg/d), rifampin (600 mg/d), and pyrazinamide (1,500 mg/d) in 29 adults (14 patients infected
Publikováno v:
Scopus-Elsevier
Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile char
Publikováno v:
Scopus-Elsevier
The effect of a therapeutic dose of fluconazole on the disposition of zidovudine was evaluated in 12 men infected with human immunodeficiency virus. The study was designed as a randomized, two-period, two-treatment, crossover trial. On two occasions,
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:894-897
The antacids in two didanosine placebo tablets had no significant effect on the plasma pharmacokinetics of a single oral dose of 300 mg of isoniazid administered to 12 healthy volunteers. These results suggest that isoniazid bioavailability will be u
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:550-554
Vancomycin-induced "red man syndrome" (RMS) is mediated in part by histamine release, and its severity is correlated with the area under the plasma histamine concentration-time curve. Ten adult male volunteers participated in a randomized, double-bli
Publikováno v:
Drug Interactions in Infectious Diseases ISBN: 9781475750317
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead86d8980a86b667811f913d1fd94fa
https://doi.org/10.1385/1-59259-025-x:1
https://doi.org/10.1385/1-59259-025-x:1
Autor:
Francisco Diaz-Mitoma, Jan Sahai, Lionel G. Filion, Frédéric Baribaud, Daniel S. Sitar, Michael J. Orsini, Robert W. Doms, Benjamin J. Doranz, Jeffrey L. Benovic, William Cameron
Publikováno v:
AIDS research and human retroviruses. 17(6)
ALX40-4C is a small peptide inhibitor of the chemokine receptor CXCR4 that can inhibit X4 strains of HIV-1. Prior to the discovery of chemokine receptors as the HIV coreceptors, ALX40-4C was used in phase I/II clinical trials to evaluate its therapeu
Autor:
Jan Sahai, K Gallicano
Publikováno v:
British journal of clinical pharmacology. 42(5)
The influence of gender on the single-dose pharmacokinetics of oral ciprofloxacin was investigated in a parallel designed study in 24 healthy, fasted volunteers. Ciprofloxacin (750 mg) was administered as a single tablet to 10 women and 14 men. All s
Publikováno v:
Scopus-Elsevier
Our objective was to determine whether a pharmacokinetic interaction exists between zidovudine and didanosine when they are coadministered. This was designed as a randomized, three-period, three-treatment, six-sequence, crossover study with a 1-week
Autor:
Jan Sahai
Publikováno v:
Annals of internal medicine. 123(5)